Pre-Conference Programme

HEPATITIS ELIMINATION WORKSHOP 

With the arrival of the era of DAA therapy, we are now able to access high efficacy oral therapy and achieve HCV cure with short duration therapy. The focus is now to eradicate HCV. Efforts to achieve this require commitment from government, public sector and private sectors. The role of infrastructure, addressing barriers to care and lessons learnt from successful models can then be applied. The concept of micro-elimination appears to be an emerging idea that allows targets to be achieved.

In this pre-conference Hepatitis Elimination Workshop, we gather in Asia relevant parties to discuss both the targets, concepts, barriers and achievements, bringing together experts from WHO, patient advocacy, public health, hepatologists and the private sector to discuss successful models for hepatitis eradication.

This symposium will be one of the few in Asia to address this important unmet need, and we encourage all those interested to attend and participate in this exciting venture.

All registered participants are welcome to attend this workshop* Please confirm your attendance at info@shc-sg.com as seats are limited and registrations are on a first-come, first-served basis.

Important: *Delegates who are interested to attend the Pre-Conference workshops must register for the main conference here

HEPATITIS ELIMINATION WORKSHOP 
  • Date:                    Thursday, 7 June 2018
  • Time:                    12:00 - 18:00
  • Venue:                  Summit 2, Level 3, Suntec Singapore

Time

Programme

Opening Lecture

12:30

WHO strategy and goals for viral hepatitis Eradication & cascade of care

Overcoming Barriers

12:45

Do we really know the scope of the problem?

13:00

What are the most effective strategies to improve screening uptake?

13:15

Risk reduction strategies

13:30

Round table discussion

Infrastructure Requirements

14:00

Improving access to therapy

14:15

Infrastructure needed for monitoring and delivery of therapy in resource constrained settings

14:30

Hepatitis Notification systems and Patient registries

14:45

Round table discussion

15:15

Coffee Break

Elimination Strategies

15:30

Micro-elimination, an emerging concept

15:45

Simplifying management

16:00

Lessons from country specific success stories in HCV eradication

16:15

Round table discussion

Working Together

16:45

Setting the agenda – the role of Government

17:00

The role of patients

17:15

The role of NGOs

17:30

Partnerships between Government, NGO and industry

17:45

Round Table discussion

18:15

Discussion Forum: All speakers

ULTRASOUND/FIBROSCAN WORKSHOP 

Two Innovators, One Goal - FibroScan + Shear wave Elastography Ultrasound Workshop

This workshop will give insights and hands on experience on the LOGIQ S8, the only ultrasound system on the market with an integrated Fibroscan.

Improve diagnostic accuracy and outcomes with liver these quantification methods. Two innovators with one goal - GE and Echosens is helping clinicians improve outcomes of early stages of liver disease.

Find out more in this workshop, reduce the need for liver biopsy and enhance early detection of fibrosis and steatosis.

All registered participants are welcome to attend this workshop* Please confirm your attendance at info@shc-sg.com as seats are limited and registrations are on a first-come, first-served basis.

Important: *Delegates who are interested to attend the Pre-Conference workshops must register for the main conference here

ULTRASOUND / FIBROSCAN WORKSHOP 
  • Date:                     Thursday, 7 June 2018
  • Time:                     Session 1: 09:30 - 12:30 / Session 2: 14:00 - 17:30
  • Venue:                   Room 332, Level 3, Suntec Singapore

 

Topic Highlights

  1. Ultrasound of Liver
  2. How to use Ultrasound to guide fibroscan
  3. Interpreting results – application of the charts to ASEAN population and certain types of liver disease groups
  4. Liver 2D SWE and its current role in patient management
  5. Pitfalls of Fibroscan without ultrasound guidance 2D SWE compare/contrast with Fibroscan – then conclude with the benefits of having both1
  6. Cost benefit of early diagnosis of steatosis